2023 Research & Development Revenue of $18.1 Million Expected to Increase to $28.0 Million in 2024 Commercialization Underway with Revenue Expected in 2H 2024 for DeepView AI®-Burn Indication in.
Five QHINs have completed the onboarding process, according to ONC, and will now drive higher levels of healthcare information interoperability across the United States.
The health system partnered with Premera Blue Cross to pilot a new data-as-a-service product that uses the HL7 Da Vinci Project’s clinical exchange standards to improve VBC delivery.
Highlights Continuing Progress in Developing and Commercializing AI-Driven DeepView® System Wound Healing Assessment Technology Affirms Full Year Revenue.